The pharmaceutical industry has long struggled with sky-high costs, lengthy development timelines, and an overwhelming failure rate in drug discovery. Now, a wave of AI-driven startups is aiming to change that. By adopting an AI-first business model, these companies are using computational power to accelerate the identification of life-saving therapeutics. One company leading this transformation […] The post AI-First Business Models Seek to Resh…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.